Literature DB >> 2935979

Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow.

S J Noga, A D Donnenberg, C L Schwartz, L C Strauss, C I Civin, G W Santos.   

Abstract

Graft-versus-host disease (GVHD) remains a major complication of allogeneic bone marrow (BM) transplantation. Techniques that effectively purge BM of mature T lymphocytes should reduce the incidence of GVHD and improve survival. We have developed a simplified, two-flow rate, fixed rotor speed counterflow centrifugation-elutriation (CCE) procedure that reproducibly depletes 99% of lymphocytes from Ficoll-Hypaque(F/H)-separated BM or BM buffy-coat. Two predetermined flow rates (24 and 28 ml/min) were used to purge small and intermediate-to-large lymphocytes, respectively, whereas faster sedimenting cells were recovered at the termination of the run. Lymphocyte depletion was substantiated by pan-T monoclonal antibody analysis as well as by complete loss of responsiveness to alloantigens and mitogens. Despite the lack of mature T cells, the depleted marrow fraction retained lymphoid colony-forming ability. Lymphocyte-purged marrow was obtained in high yield (72%), and retained high viability (greater than 97%) and hematopoietic colony-forming ability (greater than 99%). The ratio of total myeloid/erythroid colony-forming cells to T lymphocytes was 73-fold higher in the lymphocyte-depleted fraction than in unseparated BM. We concluded that a two-step CCE procedure can be used to rapidly deplete lymphocytes from both F/H-separated and buffy-coat BM inocula without altering hematopoietic capacity as measured by the in vitro clonogenic assays. It may be possible to adapt this procedure to the separation of the large number of marrow cells required for human BM transplantation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2935979     DOI: 10.1097/00007890-198602000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.

Authors:  L G Lum; E Burns; M M Janson; P J Martin; B R Giddings; M C Seigneuret; J E Noges; S C Galoforo
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

Review 2.  Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.

Authors:  David A Jacobsohn; Georgia B Vogelsang
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  T cell depletion in paediatric stem cell transplantation.

Authors:  C Booth; P Veys
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

4.  Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes.

Authors:  A C Fischer; A D Hess
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.